StockVS

Archimedes Tech SPAC Partners III Co. (ARCI) Análisis de acciones

Servicios Financieros

Archimedes Tech SPAC Partners III Co.

$9.96

+$0.00 (+0.00%)

Última actualización: 26 de mayo de 2026

Historial de Precios

Análisis

Descripción de la empresa

Archimedes Tech SPAC Partners III Co. operates within the financial services sector, specifically functioning as a shell company dedicated to facilitating mergers, amalgamations, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations with one or more target businesses. As a Special Purpose Acquisition Company (SPAC), its primary mandate is not to conduct operations immediately but to raise capital and seek a merger with an operating company to provide a public market listing for that entity. The company is currently valued at a market capitalization of $348.74 million, reflecting the aggregate market value of its outstanding shares, while it maintains an employee count that is not publicly disclosed in available filings. These financial metrics indicate that the entity possesses a significant amount of equity capital available for deployment into a merger transaction, yet the absence of traditional operational revenue suggests its valuation is derived entirely from its potential to complete a business combination rather than current earnings generation.

Salud financiera

The financial performance of Archimedes Tech SPAC Partners III Co. is characterized by a net income of $-166,850 over the trailing twelve-month period, while both revenue and EBITDA figures are currently reported as not available. This gap between non-existent revenue and negative net income reveals that the company incurs operational expenses and management fees necessary to maintain its corporate structure and comply with regulatory requirements, even in the absence of income-producing activities. The company reports a free cash flow that is not available for public disclosure, indicating that cash generation is currently constrained by the costs of holding a shell status and searching for a merger target rather than by operational cash flows. Analysis of the three primary margins—gross margin, operating margin, and profit margin—shows that each is recorded at 0.0%, a standard characteristic for SPACs that have not yet merged with an operating business and therefore have no cost of goods sold or operating income to generate a positive spread. Regarding liquidity and leverage, the company's cash and total debt positions are both listed as not available, while the debt-to-equity ratio is also not available, preventing a definitive assessment of whether the balance sheet is conservative or leveraged in the traditional sense of an operating firm. However, the current ratio is recorded at 0.11, which indicates a level of short-term liquidity where current assets are significantly lower than current liabilities, a condition typical for shell companies that may rely on equity financing or merger proceeds to meet obligations. Furthermore, the return on equity and return on assets are both listed as not available, meaning that management effectiveness cannot be evaluated through traditional return metrics until the SPAC completes a merger and begins generating returns on its capital base.

Evaluación de valoración

The trailing P/E ratio and forward P/E ratio for Archimedes Tech SPAC Partners III Co. are both listed as not available, which implies that there are no expected earnings trajectories to evaluate because the company has not yet generated positive earnings from operations. Despite the lack of standard valuation multiples, the price-to-book ratio is reported at -1098.89, a negative figure that indicates the market capitalization exceeds the book value in a way that reflects the negative equity or specific accounting treatment of unamalgamated SPACs, rather than a traditional market premium over tangible assets. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are also not available, suggesting that analysts cannot value the stock based on revenue multiples or enterprise value relative to earnings because the underlying financial data for these calculations is absent. In terms of price movement, the stock has a 52-week high of $9.94 and a 52-week low of $9.83, meaning the current trading price sits in a very narrow range near the lower bound of its annual volatility, reflecting the low liquidity and speculative nature of shell company stocks. The beta value is not available, which prevents a direct comparison of the stock's price volatility relative to the broader market, though the tight trading range suggests limited price fluctuation driven by the company's specific merger search status.

Growth & Income

The revenue growth and earnings growth rates for Archimedes Tech SPAC Partners III Co. are both listed as not available, as the company has not yet generated the sustained revenue streams necessary to calculate year-over-year growth percentages. Since the earnings are negative and revenue is effectively nil, there is no basis to determine whether earnings are growing faster or slower than revenue, as both metrics remain static at their pre-merger baseline. The company does not pay dividends, as indicated by the not available dividend yield and payout ratio, meaning that any profits generated from interest income or merger proceeds are entirely reinvested into the search for a merger target rather than distributed to shareholders. Consequently, the overall growth and income profile of Archimedes Tech SPAC Partners III Co. is defined by its potential to realize value through a successful business combination rather than through organic revenue expansion or dividend income distribution.

Comparación con pares

Archimedes Tech SPAC Partners III Co. (ARCI) opera en la industria de Empresas Fantasma. Así se compara con sus pares más cercanos por capitalización de mercado:

Empresa Ticker Cap. de Mercado Ratio P/E
Archimedes Tech SPAC Partners III Co. ARCI $351.21M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

El ratio P/E promedio de la industria Empresas Fantasma es 82.8x. Archimedes Tech SPAC Partners III Co. cotiza a un P/E de N/A.

Este análisis es generado por IA solo con fines informativos y no constituye asesoramiento financiero. Los datos pueden estar retrasados o ser inexactos. Siempre realice su propia investigación y consulte a un asesor financiero calificado antes de tomar decisiones de inversión.

Acerca de Archimedes Tech SPAC Partners III Co.

Archimedes Tech SPAC Partners III Co. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Claymont, Delaware.

La descripción de la empresa se muestra en inglés.

Visitar sitio web →

Estadísticas Clave

Capitalización
$351.21M
Ratio P/E
N/A
Máximo 52 Sem.
$10.06
Mínimo 52 Sem.
$9.83
Volumen Promedio
38.43K

Datos proporcionados por Yahoo Finance a través de yfinance. Actualizado diariamente.

Información de la Empresa

Bolsa
NASDAQ
País
United States